A 54-year-old obese woman with type 2-diabetes and has been recently found to have end stage renal disease with GFR 20. Her physical prescribed oral antidiabetic agents but advised her to avoid taking metformin What is the single risk of using metformin for this patient?
سؤال مجاني 7 من 10 اليوم · اشترك وكمّل بدون حد
اعرض الإجابة
الإجابة والشرح
ادخل لحسابك عشان نحفظ إجاباتك ونوريك أخطاءك.
الإجابة: C. Lactic acidosis
Metformin is renally cleared. Its feared adverse effect is lactic acidosis, and it is contraindicated when eGFR is below 30 (her GFR is 20). Metformin does not cause hypoglycaemia or weight gain on its own.
ليش كل خيار صح أو غلط
-
A
ليش غلط
Metformin is listed as not causing hypoglycaemia; sulfonylureas and insulin are the drugs with that risk.
✓ RT - DM.pdf · p. 10 -
B
ليش غلط
Metformin does not cause weight gain and is described as ideal for obese patients.
✓ Anti-diabetic.pdf · p. 2 -
C
ليش صح
Metformin's listed hazard is lactic acidosis, and it is contraindicated when eGFR is below 30; her GFR is 20.
✓ RT - DM.pdf · p. 10 -
D
ليش غلط
Metformin is not metabolised and is excreted unchanged in the urine; the danger listed for renal patients is lactic acidosis.
✓ Anti-diabetic.pdf · p. 2
- المصدر
- RT - DM.pdf · p. 10
- المحاضرة
- Diabetes Mellitus · Endocrinology · Module B
- ظهر في
- Endo bank